XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
9 Months Ended
Oct. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
Fair Value Measured as of October 31, 2021
Level 1Level 2Level 3Total
(in thousands)
Assets
Money market funds$254,714 $— $— $254,714 
Total financial assets$254,714 $— $— $254,714 
Liabilities
Common stock warrant liabilities (Private Placement)$— $— $29,282 $29,282 
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)— — 3,856 3,856 
Total financial liabilities$— $— $33,138 $33,138 

Fair Value Measured as of January 31, 2021
Level 1Level 2Level 3Total
(in thousands)
Assets
Money market funds$109,703 $— $— $109,703 
Total financial assets$109,703 $— $— $109,703 
Liabilities
Redeemable convertible preferred stock warrant liability$— $— $75,843 $75,843 
Total financial liabilities$— $— $75,843 $75,843 
Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:

Redeemable convertible preferred stock warrant liabilityPrivate placement warrant liabilityEarnout liability and ViriCiti Earnout liability
(in thousands)
Fair value as of January 31, 2021$(75,843)$— $— 
Private placement warrant liability acquired as part of the merger— (127,888)— 
Contingent earnout liability recognized upon the closing of the reverse recapitalization
— — (828,180)
Change in fair value included in other income (expense), net9,237 46,835 84,420 
Reclassification of warrants to stockholders’ equity (deficit) due to exercise— 51,771 — 
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization66,606 — — 
Issuance of earnout shares upon triggering events— — 501,120 
Reclassification of remaining contingent earnout liability upon triggering event
— — 242,640 
Contingent earnout liability recognized upon the acquisition of ViriCiti (ViriCiti Earnout)— — (3,856)
Fair value as of October 31, 2021$— $(29,282)$(3,856)